Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04385901 · ClinicalTrials.gov registry record · NA
Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT04385901: Completed NA study, sponsored by University of Missouri-Columbia.
NCT04385901 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04385901, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study seeks to assess the impact of physical and pulmonary rehabilitation on patients who have been diagnosed with COVID-19 in the short and long term in hopes of establishing a best practices protocol for treatment of future patients with this disease.
Primary Outcome
Validated test demonstrating functional gait capacity and endurance; measuring change in capacity over time in 6 month increments.
Interventions
- BEHAVIORAL Therapy Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2020-05-19 |
| Est. Completion | 2020-09-19 |
| Phase | NA |
What the finished NCT04385901 record still lists
NCT04385901 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Therapy Intervention is the first listed.
NCT04385901 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04385901 about?
NCT04385901 is a clinical study titled "Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth". This study seeks to assess the impact of physical and pulmonary rehabilitation on patients who have been diagnosed with COVID-19 in the short and long term in hopes of establishing a best practices protocol for treatment of future patients with this disease.
What is the current status of trial NCT04385901?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2020-05-19. Estimated completion is 2020-09-19.
What interventions are being tested in trial NCT04385901?
The interventions under investigation include: Therapy Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04385901?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04385901's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI